1192
Y.-Q. Wang, Y.-G. Zhou
LETTER
by reduction of the corresponding imines using NaBH4 in
THF. For the preparation of complexes and other
experimental details, see reference 8.
Hz, 1 H), 4.33–4.40 (m, 1 H), 7.24 (dd, J = 8.5, 23.0 Hz, 4
H), 7.37–7.47 (m, 6 H), 7.79 (dd, J = 7.0, 12.0, 2 H), 7.90
(dd, J = 6.9, 11.9 Hz, 2 H).
(15) Compound 1c: white solid. 1H NMR (400 MHz, CDCl3):
d = 2.95 (d, J = 1.8 Hz, 3 H), 7.12–7.17 (m, 2 H), 7.43–7.45
(m, 6 H), 7.94–7.99 (m, 4 H), 8.09–8.12 (m, 2 H). 13C NMR
(100 MHz, CDCl3): d = 23.1 (d, J = 12.3 Hz), 115.8 (d,
J = 21.7 Hz), 128.6 (d, J = 12.3 Hz), 130.6 (d, J = 8.9 Hz),
131.7, 131.8, 134.8 (d, J = 130.2 Hz), 135.9 (d, J = 25.8 Hz),
165.7 (d, J = 252.7 Hz), 180.2 (d, J = 7.0 Hz). 31P NMR (162
MHz, CDCl3): d = 19.1. HRMS (ESI): m/z calcd for
C20H18FNOP [M + H+]: 338.1105; found: 338.1082.
Compound 1f: white solid. 1H NMR (400 MHz, CDCl3):
d = 2.95 (d, J = 2.1 Hz, 3 H), 3.88 (s, 3 H), 7.10 (m, 1 H),
7.39–7.46 (m, 7 H), 7.64 (d, J = 2.4 Hz, 2 H), 7.95–8.00 (m,
4 H). 13C NMR (100 MHz, CDCl3): d = 23.3 (d, J = 12.4
Hz), 55.6, 113.6, 117.9, 120.7, 128.6 (d, J = 12.4 Hz), 129.7,
131.6, 131.7 (d, J = 9.0 Hz), 134.8 (d, J = 130.3 Hz), 141.0
(d, J = 23.9 Hz), 159.8, 181.5 (d, J = 7.5 Hz). 31P NMR (162
MHz, CDCl3): d = 19.3. HRMS (ESI): m/z calcd for
C21H21NO2P [M + H+]: 350.1304; found: 350.1297.
Compound 1g: white solid. 1H NMR (400 MHz, CDCl3):
d = 2.89 (d, J = 2.0 Hz, 3 H), 3.82 (d, J = 2.4 Hz, 3 H), 6.93
(d, J = 8.3 Hz, 1 H), 7.00 (s, 1 H), 7.40–7.45 (m, 7 H), 7.63
(dd, J = 1.7, 7.6 Hz, 1 H), 7.93–7.99 (m, 4 H). 13C NMR (100
MHz, CDCl3): d = 28.3 (d, J = 13.6 Hz), 55.5, 111.6, 120.6,
128.4 (d, J = 12.3 Hz), 129.9, 131.4, 131.8 (d, J = 8.9 Hz),
132.3, 134.9 (d, J = 129.2 Hz), 158.0, 186.0 (d, J = 7.6 Hz).
31P NMR (162 MHz, CDCl3): d = 18.5. HRMS (ESI): m/z
calcd for C21H21NO2P [M + H+]: 350.1304; found: 350.1288.
Compound 2a: white solid; 95.3% ee (R); [a]D26 +38.3 (c
0.54, EtOH); Rf 0.14 (PE–EtOAc, 2:1); HPLC (Chiralpak
AS-H column, hexane–i-PrOH, 20:80, 1.0 mL/min, 254
nm): tR 12.9 min (R), tR 24.4 min (S). 1H NMR (400 MHz,
CDCl3): d = 1.58 (d, J = 6.7 Hz, 3 H), 3.17 (dd, J = 5.9, 9.1
Hz, 1 H), 4.36–4.43 (m, 1 H), 7.26–7.45 (m, 11 H), 7.80–
7.85 (m, 2 H), 7.89–7.93 (m, 2 H).
Compound 2e: white solid; 96.0% ee (S); [a]D8 –66.4 (c
1.30, MeOH); HPLC (Chiralpak AS-H column, hexane–i-
PrOH, 80:20, 1.0 mL/min, 254 nm): tR 15.9 min (R), tR 26.8
min (S). 1H NMR (400 MHz, CDCl3): d = 1.55 (d, J = 6.7
Hz, 3 H), 3.12 (dd, J = 5.9, 9.4 Hz, 1 H), 3.80 (s, 3 H), 4.31–
4.41 (m, 1 H), 6.85 (d, J = 8.7 Hz, 2 H), 7.21 (d, J = 8.7 Hz,
2 H), 7.37–7.48 (m, 6 H), 7.81–7.91 (m, 4 H).
Compound 2f: white solid; 96.0% ee (S); [a]D8 –52.1 (c 1.32,
MeOH); Rf 0.38 (PE–EtOAc, 1:1); HPLC (Chiralpak AS-H
column, hexane–i-PrOH, 80:20, 1.0 mL/min, 254 nm):
tR 14.5 min (R), tR 29.4 min (S). 1H NMR (400 MHz,
CDCl3): d = 1.57 (d, J = 6.8 Hz, 3 H), 3.22 (dd, J = 5.9, 9.5
Hz, 1 H), 3.78 (s, 3 H), 4.31–4.39 (m, 1 H), 6.82–6.88 (m, 3
H), 7.21–7.23 (m, 1 H), 7.36–7.47 (m, 6 H), 7.80–7.93 (m, 4
H).
Compound 2g: white solid; 98.6% ee (S); [a]D8 –22.1 (c
1.13, MeOH); Rf 0.33 (PE–EtOAc, 1:1). HPLC (Chiralpak
AS-H column, hexane–i-PrOH, 80:20, 1.0 mL/min, 254
nm): tR 11.9 min (R), tR 21.3 min (S). 1H NMR (400 MHz,
CDCl3): d = 1.50 (d, J = 6.8 Hz, 3 H), 3.69 (s, 3 H), 3.87 (dd,
J = 8.0, 10.5 Hz, 1 H), 4.36–4.43 (m, 1 H), 6.78–6.82 (m, 2
H), 6.97 (s, 1 H), 7.19 (t, J = 7.7 Hz, 1 H), 7.33–7.38 (m, 6
H), 7.72 (dd, J = 7.3, 11.9 Hz, 2 H), 7.79 (dd, J = 7.1, 11.8
Hz, 2 H). 13C NMR (100 MHz, CDCl3): d = 25.1, 49.6, 55.4,
111.2, 121.0, 128.3 (d, J = 7.0 Hz), 128.5, 131.7, 131.8,
128.1 (d, J = 108.6 Hz), 131.7, 131.8, 132.0 (d, J = 9.3 Hz),
132.8 (d, J = 9.4 Hz), 133.0, 133.1, 133.8 (d, J = 119.7 Hz),
157.0. 31P NMR (162 MHz, CDCl3): d = 22.9. HRMS (ESI):
m/z calcd for C21H23NO2P [M + H+], 352.1461; found,
352.1451.
Compound 2h: white solid; 86.7% ee (S); [a]D8 –38.5 (c
1.26, MeOH); Rf 0.31 (PE–EtOAc, 1:1); HPLC (Chiralpak
AS-H column, hexane–i-PrOH, 80:20, 1.0 mL/min, 254
nm): tR 9.6 min (R), tR 17.7 min (S). 1H NMR (400 MHz,
CDCl3): d = 0.79 (t, J = 7.4 Hz, 3 H), 1.80–1.89 (m, 1 H),
1.97–2.04 (m, 1 H), 3.25 (dd, J = 6.4, 9.4 Hz, 1 H), 4.08–
4.11 (m, 1 H), 7.14–7.16 (m, 2 H), 7.23–7.33 (m, 5 H), 7.42–
7.44 (m, 4 H), 7.73–7.87 (m, 4 H).
Compound 2b: white solid; 96.6% ee (S); [a]D8 –66.5 (c
1.08, MeOH); Rf 0.22 (PE–EtOAc, 2:1); HPLC (Chiralpak
AS-H column, hexane–i-PrOH, 80–20, 1.0 mL/min, 254
nm): tR 11.4 min (R), tR 15.8 min (S). 1H NMR (400 MHz,
CDCl3): d = 1.56 (d, J = 6.8 Hz, 3 H), 2.34 (s, 3 H), 3.14–
3.17 (m, 1 H), 4.32–4.39 (m, 1 H), 7.15 (dd, J = 8.0, 20.4 Hz,
4 H), 7.37–7.48 (m, 6 H), 7.81–7.91 (m, 4 H).
Compound 2i: white solid; 92.8% ee (S); [a]D8 –77.8 (c 1.02,
MeOH); Rf 0.39 (PE–EtOAc, 1:1); HPLC (Chiralpak AS-H
column, hexane–i-PrOH, 80:20, 1.0 mL/min, 254 nm):
tR 21.6 min (R), tR 27.7 min (S). 1H NMR (400 MHz,
CDCl3): d = 1.66 (d, J = 6.7 Hz, 3 H), 3.27–3.31 (m, 1 H),
4.51–4.61 (m, 1 H), 7.32–7.33 (m, 2 H), 7.43–7.48 (m, 7 H),
7.65 (s, 1 H), 7.80–7.83 (m, 5 H), 7.93 (m, 2 H).
Compound 2c: white solid; 94.0% ee (S); [a]D8 –41.9 (c
1.04, MeOH); Rf 0.18 (PE–EtOAc, 2:1); HPLC (Chiralpak
AS-H column, hexane–i-PrOH, 80:20, 1.0 mL/min, 254
nm): tR 10.0 min (R), tR 27.0 min (S). 1H NMR (400 MHz,
CDCl3): d = 1.55 (d, J = 6.8 Hz, 3 H), 3.11 (dd, J = 5.9, 9.2
Hz, 1 H), 4.35–4.42 (m, 1 H), 6.98 (t, J = 8.7 Hz, 2 H), 7.23–
7.25 (m, 2 H), 7.36–7.37 (m, 2 H), 7.44–7.46 (m, 4 H), 7.78–
7.81 (m, 2 H), 7.88–7.92 (m, 2 H).
Compound 2j: white solid, 87.0% ee (S), [a]D8 –42.1 (c 0.60,
CH2Cl2); Rf 0.34 (PE–CH2Cl2,1:4); HPLC (Chiralpak AS-H
column, hexane–i-PrOH, 80:20, 1.0 mL/min, 254 nm):
tR 12.1 min (R), tR 17.0 min (S). 1H NMR (400 MHz,
CDCl3): d = 1.60 (d, J = 6.8 Hz, 3 H), 3.19 (dd, J = 6.6, 10.3
Hz, 1 H), 4.38–4.44 (m, 1 H), 6.13 (d, J = 3.2 Hz, 1 H), 6.28
(dd, J = 1.9, 3.2 Hz, 1 H), 7.35 (m, 1 H), 7.42–7.49 (m, 6 H),
7.87–7.95 (m, 4 H).
Compound 2d: white solid; 94.2% ee (S); [a]D8 –73.4 (c
1.14, MeOH); Rf 0.33 (PE–EtOAc, 1:1); HPLC (Chiralpak
AS-H column, hexane–i-PrOH, 80:20, 1.0 mL/min, 254
nm): tR 11.4 min (R), tR 26.3 min (S). 1H NMR (400 MHz,
CDCl3): d = 1.55 (d, J = 6.8 Hz, 3 H), 3.17 (dd, J = 5.7, 9.5
Synlett 2006, No. 8, 1189–1192 © Thieme Stuttgart · New York